| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL0500116 | 注射用重组人干扰素α2a与肿瘤血管特异性结合多肽NGR融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2006-03-24 | 陕西九州生物科技股份有限公司 | Shaanxi Jiuzhou Biotechnology Co Ltd | Certificate Issued | 2009-06-03 | view |